Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-21-000084

CFO and Treasurer sold 2,285 shares at an average $49.57 ($113,263)

From the SEC's structured data for this filing

Trades in this filing

Krognes Steve E. · CFO and Treasurer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-19 Sale : show line 1 in the form −2,085 $49.52 $103,249 95,502 D
2021-08-19 Sale : show line 2 in the form −200 $50.07 $10,014 95,302 D
Open-market sales · 2,285 sh · avg $49.57 · $113,263
Loading xslF345X03/wf-form4_162976465052657.xml…